GSK and Oxford researchers to create cancer vaccine to stop disease developing

The University of Oxford and GSK are to work on a vaccine to target cells in the pre-cancerous stage (PA)

Pharmaceutical giant GSK and the University of Oxford are creating a new cancer vaccine to prevent the disease from developing.

The partnership intends to create a vaccine or vaccines which target cells at the pre-cancerous stage before the disease has taken hold and begun to wreak havoc on the body.